{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:43:43Z","timestamp":1770335023206,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1378\/chest.124.3.834","type":"journal-article","created":{"date-parts":[[2003,9,11]],"date-time":"2003-09-11T16:35:50Z","timestamp":1063298150000},"page":"834-843","source":"Crossref","is-referenced-by-count":227,"title":["The Efficacy and Safety of Fluticasone Propionate (250 \u03bcg)\/Salmeterol (50 \u03bcg) Combined in the Diskus Inhaler for the Treatment of COPD"],"prefix":"10.1016","volume":"124","author":[{"given":"Nicola A.","family":"Hanania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Darken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Horstman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Reisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.124.3.834_bib1","first-page":"S77","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease","volume":"152","author":"American Thoracic Society","year":"1995","journal-title":"Am J Respir Care Med"},{"key":"10.1378\/chest.124.3.834_bib2","first-page":"1","article-title":"Chronic obstructive pulmonary disease surveillance: United States, 1971\u20132000","volume":"51","author":"Mannino","year":"2002","journal-title":"MMWR CDC Surveill Summ"},{"key":"10.1378\/chest.124.3.834_bib3","doi-asserted-by":"crossref","first-page":"345S","DOI":"10.1378\/chest.117.5_suppl_2.354S","article-title":"The prevalence of COPD: using smoking rates to estimate disease frequency in the general population","volume":"117","author":"Stang","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.124.3.834_bib4","first-page":"1","article-title":"Research for the 1995\u20132004 redesign","volume":"126","author":"National Health Interview Survey","year":"1999","journal-title":"Vital Health Stat 2"},{"issue":"Suppl","key":"10.1378\/chest.124.3.834_bib5","first-page":"5S","article-title":"The economic burden of COPD","volume":"117","author":"Sullivan","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.124.3.834_bib6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary","volume":"163","author":"Pauwels","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/ajrccm.155.2.9032192","article-title":"Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD","volume":"155","author":"Keatings","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib8","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1164\/ajrccm.160.5.9811058","article-title":"Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease","volume":"160","author":"Culpitt","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/ajrccm.164.3.2002052","article-title":"Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction","volume":"164","author":"O\u2019Brien","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1164\/ajrccm\/146.2.389","article-title":"Aerosolized beclomethasone in chronic bronchitis","volume":"146","author":"Thompson","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.124.3.834_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1164\/ajrccm.153.2.8564107","article-title":"Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema","volume":"153","author":"Llewellyn-Jones","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/thx.53.7.583","article-title":"Inhaled corticosteroids reduce neutrophilic bronchial inflammation I patients with chronic obstructive pulmonary disease","volume":"53","author":"Confalonieri","year":"1998","journal-title":"Thorax"},{"key":"10.1378\/chest.124.3.834_bib13","first-page":"A524","article-title":"Effect on an inhaled glucocorticoid, fluticasone propionate on inflammation in bronchial biopsies of COPD patients with bronchial hyperresponsiveness","volume":"159","author":"Verhoeven","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib14","first-page":"A523","article-title":"A double-blind placebo-controlled trial of the effect of inhaled corticosteroids on the immunopathology of COPD [abstract]","volume":"159","author":"Hattotuwa","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib15","first-page":"A491","article-title":"Inhaled steroids decreases mast cells in moderate to severe COPD [abstract]","volume":"161","author":"Hattotuwa","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1378\/chest.117.6.1633","article-title":"Inhaled corticosteroids in stable COPD patients: do they have effects on cells and molecular mediators of airway inflammation","volume":"117","author":"Balbi","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.124.3.834_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000029466","article-title":"Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease","volume":"67","author":"Yildiz","year":"2000","journal-title":"Respiration"},{"key":"10.1378\/chest.124.3.834_bib18","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1164\/rccm.2105025","article-title":"The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo- controlled biopsy study","volume":"165","author":"Hattotuwa","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/thx.46.5.372","article-title":"Effects of inhaled budesonide on spirometry, reversibility, airway responsiveness and cough threshold in smokers with COPD","volume":"46","author":"Auffarth","year":"1991","journal-title":"Thorax"},{"key":"10.1378\/chest.124.3.834_bib20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199211123272003","article-title":"A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease: Dutch Chronic Non-Specific Lung Disease Study Group","volume":"327","author":"Kerstjens","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.124.3.834_bib21","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1378\/chest.108.6.1568","article-title":"Inhaled budesonide therapy for patients with stable COPD","volume":"108","author":"Weiner","year":"1995","journal-title":"Chest"},{"key":"10.1378\/chest.124.3.834_bib22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1164\/ajrccm\/140.6.1527","article-title":"Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters","volume":"140","author":"Thompson","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.124.3.834_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.93.05080945","article-title":"Inhaled beclomethasone improves the course of asthma and COPD","volume":"5","author":"Dompeling","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.124.3.834_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(97)03471-5","article-title":"Multicentre randomized, placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease","volume":"351","author":"Paggiaro","year":"1998","journal-title":"Lancet"},{"key":"10.1378\/chest.124.3.834_bib25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1378\/chest.124.3.834_bib26","first-page":"343","article-title":"Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease","author":"Lung Health Study Research Group","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.124.3.834_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1183\/09031936.01.17303800","article-title":"Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics","volume":"17","author":"Sin","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.124.3.834_bib28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1164\/ajrccm.163.5.9903053","article-title":"Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease","volume":"163","author":"Rennard","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1378\/chest.115.4.957","article-title":"Efficacy of salmeterol xinafoate in the treatment of COPD","volume":"115","author":"Mahler","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.124.3.834_bib30","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1164\/ajrccm.155.4.9105068","article-title":"Quality of life changes in COPD patients treated with salmeterol","volume":"155","author":"Jones","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1476-5381.1991.tb12487.x","article-title":"Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung","volume":"104","author":"Butchers","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1378\/chest.124.3.834_bib32","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1152\/jappl.1996.80.5.1666","article-title":"Differential effects of salmeterol on lung endothelial and epithelial leakage in sheep","volume":"80","author":"Petersen","year":"1996","journal-title":"J Appl Physiol"},{"key":"10.1378\/chest.124.3.834_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1476-5381.1996.tb15297.x","article-title":"Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophilsin vitro","volume":"117","author":"Anderson","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1378\/chest.124.3.834_bib34","first-page":"A597","article-title":"Salmeterol and fluticasoned dipropionate inhibit neutrophil transendothelial migration [abstract]","volume":"163","author":"Bishara","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib35","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0140-6736(90)92894-N","article-title":"Protection against allergen-induced asthma by salmeterol","volume":"336","author":"Twentyman","year":"1990","journal-title":"Lancet"},{"key":"10.1378\/chest.124.3.834_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI118084","article-title":"Protective effects of a glucocorticoid on downregulation of pulmonary beta2-adrenergic receptorsin vivo","volume":"96","author":"Mak","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.124.3.834_bib37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/ajrccm.155.2.9032216","article-title":"Glucocorticosteroids induce beta2-adrenergic receptor function in human nasal mucosa","volume":"155","author":"Baraniuk","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib38","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1074\/jbc.274.2.1005","article-title":"Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells","volume":"274","author":"Eickelberg","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1378\/chest.124.3.834_bib39","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1067\/mai.2000.105711","article-title":"Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial","volume":"105","author":"Kavuru","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.124.3.834_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/ajrccm.161.2.9905091","article-title":"Combined salmeterol 50\u03bcg and fluticasone propionate 250\u03bcg in the Diskus device for the treatment of asthma","volume":"161","author":"Shapiro","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.85.6.751","article-title":"The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes","volume":"85","author":"Mahler","year":"1984","journal-title":"Chest"},{"key":"10.1378\/chest.124.3.834_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.42.10.773","article-title":"A measure of quality of life for clinical trials in chronic lung diseases","volume":"42","author":"Guyatt","year":"1987","journal-title":"Thorax"},{"key":"10.1378\/chest.124.3.834_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.97.1.75","article-title":"The national mucolytic study: results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis","volume":"97","author":"Petty","year":"1990","journal-title":"Chest"},{"key":"10.1378\/chest.124.3.834_bib44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1378\/chest.109.2.348","article-title":"Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis","volume":"109","author":"Rubin","year":"1996","journal-title":"Chest"},{"key":"10.1378\/chest.124.3.834_bib45","first-page":"A60","article-title":"The Transition Dyspnea Index (TDI) in assessing improvements in breathlessness following tiotropium [abstract]","volume":"163","author":"Witek","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status: ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1378\/chest.124.3.834_bib47","series-title":"Cortrosyn\u00ae (cosyntropin) [package insert]","author":"Organon","year":"1999"},{"key":"10.1378\/chest.124.3.834_bib48","first-page":"351","article-title":"On the combination of independent two-sample tests of Wilcoxon","volume":"37","author":"Van Elteren","year":"1958","journal-title":"Bull Int Stat Inst"},{"key":"10.1378\/chest.124.3.834_bib49","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.2112055","article-title":"Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease","volume":"166","author":"Mahler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.3.834_bib50","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.1994.03520190043033","article-title":"Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study","volume":"272","author":"Anthonisen","year":"1994","journal-title":"JAMA"},{"key":"10.1378\/chest.124.3.834_bib51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1378\/chest.99.4.837","article-title":"Medication adherence patterns in chronic obstructive pulmonary disease","volume":"99","author":"Dolce","year":"1991","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215376376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215376376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T22:01:15Z","timestamp":1682546475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215376376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0012369215376376"],"URL":"https:\/\/doi.org\/10.1378\/chest.124.3.834","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}